2022/12/13 · Oxolife, in collaboration with Cordoba's University, will advance from preclinical to phase II clinical trials in the next 2 years.

2023/01/13 · OXOLIFE | 2435 seguidores en LinkedIn. Enhancing embryo implantation. Improving women's fertility | Oxolife: Enhancing embryo implantation.

2023/06/09 · Agnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as ...

Oxolife, developing an innovative treatment to enhance female fertility success through acting on peri/post implementation process.

2023/11/13 · Barcelona, Spain – 13th November 2023, Oxolife, the specialist biotech focused on enhancing embryo implantation in women undergoing Assisted ...

2021/02/03 · Ignasi Canals, is developing the drug OXO-001, also the first and only one of its kind, which seeks to respond to an unmet medical need: ...

Oxolife, the female fertility biotech focused on enhancing embryo implantation in women undergoing Assisted Reproductive Technology (ART) fertility ...

2021/10/01 · The trial, named OXOART-2, is aimed at demonstrating that OXO-001 improves embryo implantation compared to placebo. The study is being conducted ...

2022/12/13 · Oxolife is developing a unique new treatment designed to restore the reproductive system in a single intervention, with the potential to ...

2022/12/13 · Oxolife is developing a unique new treatment designed to restore the reproductive system in a single intervention, with the potential to ...